PT  - JOURNAL ARTICLE
AU  - Wang, Victor
TI  - A Model for the Testing and Tracing Needed to Suppress COVID-19
AID  - 10.1101/2020.06.02.20120568
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.02.20120568
4099  - http://medrxiv.org/content/early/2020/07/23/2020.06.02.20120568.short
4100  - http://medrxiv.org/content/early/2020/07/23/2020.06.02.20120568.full
AB  - This paper presents the first analytical model for calculating how many tests and tracing needed to suppress COVID-19 transmission. The number of people needs to be tested daily is given by: WhereN is the size of the population in considerationAr is the attack rate at any given timeTp is the test-positive rateρ is the percentage of infectious people that have to be detected per day. To make the effective reproduction number Re below 1, ρ must satisfy the following equation: WhereR0 is the basic reproduction number,S/N is the percentage of the susceptible population over the entire population,D is the length of the infectious period, andη is the percentage of close contacts that have to be traced.This model provides insights and guidance to deploy the testing and tracing resources optimally. An Excel model is attached to facilitate easy calculation of the number of tests and tracing needed. This model is also applicable to any infectious disease that can be suppressed by testing and tracing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A